New radiation approach shows promise for controlling small brain metastases
NCT ID NCT07405047
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a precise type of radiation called fractionated stereotactic radiotherapy (FSRT) in 33 adults with 1 to 4 small brain metastases (each 2 cm or smaller). The goal was to see if this approach could control the tumors while avoiding serious side effects like radiation necrosis. Participants received several focused radiation doses over multiple sessions. The results help doctors understand how to better treat limited brain metastases with less damage to healthy brain tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ye Zhang
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 3D camera make brain radiation safer and more precise?
- Pinpoint radiation may spare the brain in lung cancer that spreads
- Spinal fluid DNA test could personalize brain cancer therapy
- Focused radiation doses put to the test for large brain tumors
- Brain scan breakthrough: amino acid PET may solve a tricky diagnosis dilemma
- Spared brain region may shield memory during whole brain radiation